Keeping the interval consistent during titration is crucial because it helps the body build tolerance to the hormonal changes, which minimizes side effects like nausea or indigestion
The post says baseline TSH, free T4 and TPO antibodies should be established before any GLP-1 medication is started, whether branded or compounded, and that how often to recheck thyroid function during initiation is a question for the provider
FLOW trial stopped early due to evidence of renal protection with semaglutide
"I do think we're all going to have to be a little bit patient, because there is probably going to be a bit of a strain on clinics and pharmacies for the next couple of months as people very excitedly start these medications," Francavilla said
However, its important to understand that compounded medications are not FDA-approved
To be clear: No evidence has emerged of GLP-1s causing health problems on a large scale (though some studies have linked a few fatalities to hypoglycemia that emerged after using GLP-1s or an increased risk of pancreatitis or bowel obstruction)